Blood Product Utilization

There are three main utilization categories for the products of blood donation:

1. Provided to healthcare partners locally and nationally for the treatment of patients
   • Whole blood, red blood cells, and leukoreduced red blood cells for the treatment of anemia
   • Apheresis Platelets for the treatment of bleeding due to lack of platelets or platelet dysfunction
   • Fresh Frozen Plasma and Cryoprecipitate for treatment of bleeding due to lack of or dysfunction of clotting proteins
2. Provided to pharmaceutical derivative manufacturers for the preparation of blood-derived infusion products
   • Albumin and plasma protein fraction for blood volume expansion
   • Clotting factor proteins for treatment of hemophilia, von-Willibrands Disease and other clotting protein deficiencies
   • Immune globulins for treatment of general (gamma globulin) immune deficiency or specific (hepatitis B Immune Globulin, etc.) immune deficiencies
3. Provided to blood reagent manufacturers for the preparation of blood typing reagents
   • Group A and B cells for reverse blood grouping
   • Group O, antigen typed cells for antibody screening cells and for antibody identification cell panels
   • Blood Typing Serums